The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
AVIR · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | AVIR | SDGR | MIND | HAE |
|---|---|---|---|---|
| Moat Score (0–100) | 48 (highest) | 48 (highest) | 48 (highest) | 47 |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 85 (highest) | 58 | 26 | 67 |
| Pricing power | — | 88 (highest) | 44 | 76 |
| Returns on capital | 0 | 0 | 4 | 10 (highest) |
| Balance-sheet safety | 55 | 55 | 100 (highest) | 20 |
| Capital discipline | 50 | 38 | 64 (highest) | 64 (highest) |
| Price vs. high estimate | No price data | No price data | 367% above high estimate | 12% above high estimate (largest discount to high estimate) |
| Market cap | $373.1M | — | $49.8M | $3.5B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2026 | FY2026 |